BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 32502645)

  • 1. New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection.
    Patel A; Charani E; Ariyanayagam D; Abdulaal A; Denny SJ; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Sep; 26(9):1236-1241. PubMed ID: 32502645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on the Factors Associated with the Persistence of Anosmia and Ageusia in Saudi COVID-19 Patients.
    Algahtani SN; Alzarroug AF; Alghamdi HK; Algahtani HK; Alsywina NB; Bin Abdulrahman KA
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia.
    Mubaraki AA; Alrbaiai GT; Sibyani AK; Alhulayfi RM; Alzaidi RS; Almalki HS
    Saudi Med J; 2021 Jan; 42(1):38-43. PubMed ID: 33399169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anosmia and ageusia as primary symptoms of COVID-19].
    Haldrup M; Johansen MI; Fjaeldstad AW
    Ugeskr Laeger; 2020 Apr; 182(18):. PubMed ID: 32400371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of anosmia, ageusia and age in community presentation of symptomatic and asymptomatic SARS-CoV-2 infection in Louisiana, USA; a cross-sectional prevalence study.
    Feehan AK; Fort D; Velasco C; Burton JH; Garcia-Diaz J; Price-Haywood EG; Sapp E; Pevey D; Seoane L
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e9-633.e16. PubMed ID: 33421576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
    Sampaio Rocha-Filho PA; Albuquerque PM; Carvalho LCLS; Dandara Pereira Gama M; Magalhães JE
    J Headache Pain; 2022 Jan; 23(1):2. PubMed ID: 34979899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia in pediatric cases.
    Hatipoglu N; Yazici ZM; Palabiyik F; Gulustan F; Sayin I
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110469. PubMed ID: 33120100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
    Stripp TK; Søndergaard J
    Ugeskr Laeger; 2020 Apr; 182(16):. PubMed ID: 32286214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients.
    Lee Y; Min P; Lee S; Kim SW
    J Korean Med Sci; 2020 May; 35(18):e174. PubMed ID: 32383370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache associated with COVID-19: Frequency, characteristics and association with anosmia and ageusia.
    Rocha-Filho PAS; Magalhães JE
    Cephalalgia; 2020 Nov; 40(13):1443-1451. PubMed ID: 33146035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature.
    Birlutiu V; Feiereisz AI; Oprinca G; Dobritoiu S; Rotaru M; Birlutiu RM; Iancu GM
    Int J Infect Dis; 2021 Jun; 107():72-77. PubMed ID: 33887455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stringent thresholds in SARS-CoV-2 IgG assays lead to under-detection of mild infections.
    Eyre DW; Lumley SF; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Cornall RJ; Stuart DI; Screaton G; Ebner D; Crook DW; Conlon CP; Jeffery K; Walker TM; Peto TEA
    BMC Infect Dis; 2021 Feb; 21(1):187. PubMed ID: 33602152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study on the clinical features of COVID-19 with non-SARS-CoV-2 respiratory viral infections.
    Tan JY; Sim XYJ; Wee LE; Chua YY; Cherng BPZ; Ng IM; Conceicao EP; Wong TJ; Yang Y; Aung MK; Ling ML; Venkatachalam I
    J Med Virol; 2021 Mar; 93(3):1548-1555. PubMed ID: 32881022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection.
    Trachootham D; Thongyen S; Lam-Ubol A; Chotechuang N; Pongpirul W; Prasithsirikul W
    Int J Infect Dis; 2021 May; 106():329-337. PubMed ID: 33819604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review.
    Santos REA; da Silva MG; do Monte Silva MCB; Barbosa DAM; Gomes ALDV; Galindo LCM; da Silva Aragão R; Ferraz-Pereira KN
    Am J Otolaryngol; 2021; 42(2):102889. PubMed ID: 33445036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.
    Brechbühl J; Lopes AC; Wood D; Bouteiller S; de Vallière A; Verdumo C; Broillet MC
    Commun Biol; 2021 Jul; 4(1):880. PubMed ID: 34267318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.